CIK 0001624326 · Non-accelerated filer<br>Smaller reporting company
PAVmed Inc.
Sign in to watch- Ticker
- PAVM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471214177
- Phone
- (212) 949-4319
- Business address
- 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY, 10017
- Former names
- PAXmed Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-12 | Aklog Lishan Chairman and CEO | Option exercise · Subscription Rights (Right to Buy) | −980 | 0 | ||
| 2018-06-12 | Aklog Lishan Chairman and CEO | Option exercise · Series Z Warrants | +980 | 980 | ||
| 2018-06-08 | Greenspan Ira Scott 10% owner | Sale | −18,300 | $1.04 | $19K | 421,691 |
| 2018-06-01 | Greenspan Ira Scott 10% owner | Sale | −532,255 | $0.97 | $516K | 439,991 |
| 2018-04-20 | Aklog Lishan Chairman and CEO | Gift · Series Z Warrants | −12,450 | 363,313 | ||
| 2018-04-05 | Aklog Lishan Chairman and CEO | Returned to the company · Warrants | −50,450 | 0 | ||
| 2018-04-05 | Aklog Lishan Chairman and CEO | Grant or award · Series Z Warrants | +25,225 | 25,225 | ||
| 2018-04-05 | Aklog Lishan Chairman and CEO | Returned to the company · Warrants | −5,646,562 | 0 | ||
| 2018-04-05 | Aklog Lishan Chairman and CEO | Grant or award · Series Z Warrants | +2,823,281 | 2,823,281 | ||
| 2018-04-05 | Aklog Lishan Chairman and CEO | Returned to the company · Warrants | −2,220,532 | 0 | ||
| 2018-04-05 | Aklog Lishan Chairman and CEO | Grant or award · Series Z Warrants | +1,110,266 | 1,110,266 | ||
| 2018-04-05 | Aklog Lishan Chairman and CEO | Returned to the company · Warrants | −20,000 | 0 | ||
| 2018-04-05 | Aklog Lishan Chairman and CEO | Grant or award · Series Z Warrants | +10,000 | 10,000 | ||
| 2018-02-14 | Sparks Ronald M Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-02-14 | Cox James L Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-02-14 | Battleman David S. Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-02-14 | Weild IV David Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-02-14 | Glennon Michael J Vice Chairman | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2018-02-14 | DeGuzman Brian J. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 6 of 6 · 119 trades